Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.
Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad h...
Enregistré dans:
Auteurs principaux: | Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S Weiss, Wolfgang Neubert, Ulrich M Lauer, Michael Bitzer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dbf8a5eb3e6e4abe89c1df655bd5ca3a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- Oncolytic Virotherapy
-
Oncolytic Virotherapy
Publié: (2016) -
Oncolytic Virotherapy: From Bench to Bedside
par: Ludi Yang, et autres
Publié: (2021) -
ITC Sendai 2019 Special Issue: Part 1 – Papers from ITC Sendai 2019 –
par: Kazuo Hokkirigawa
Publié: (2019) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
par: D. G. Roy, et autres
Publié: (2021)